Home > Investors >Financial Information

1.Monthly Revenue

2022 net operating profit (not audited by an accountant)

unit : NTD$1,000

Month20222021Increase or decrease amountPercentage increase or decrease (%)
0164.30652,31811,98822.91
0231,42851,082-19,654-38.48
0353,08064,459-14,379-21.32
0436,23558,420-22,185-37.98
0556,24044,70211,53825.81
0656,61162,644-6.033-9.63
0771,14670,3438031.14
0885,23954,09731,14257.57
0970,84974,719-3,870-5.18
1067,21358,5057,70814.88
11104,55781,12322,43427.32
12    
合計696,904676,41320,4913.03

Historical Information

2.Financial Reports 

YearQuarter
2022Q1Q2Q3Q4 (consolidated)Q4 (individual)
2021Q1Q2Q3Q4 (consolidated)Q4 (individual)
2020Q1Q2Q3Q4 (consolidated)Q4 (individual)
2019Q1Q2Q3Q4 (consolidated)Q4 (individual)
2018Q1Q2Q3Q4 (consolidated)Q4 (individual)
2017Q1Q2Q3Q4 (consolidated)Q4 (individual)
2016Q1Q2Q3Q4 (consolidated)Q4 (individual)
2016Q1Q2Q3Q4 (consolidated)Q4 (individual)
2015Q1Q2Q3Q4 (consolidated)Q4 (individual)
2014Q1Q2Q3Q4 (consolidated)Q4 (individual)
2013Q1Q2Q3Q4 (consolidated)Q4 (individual)
2012Q2_parent company earningsQ2_parent and subsidiary consolidated statementsQ2_parent company earnings re-editedQ2_re-compilation of parent and subsidiary consolidated statementsQ3_parent company earnings
Q3_parent and subsidiary consolidated statementsQ3_parent company financial report re-editedQ3_reorganization of the consolidated statements of parent and subsidiary companies

Q4_parent company earnings

Q4_parent and subsidiary consolidated statements
2011Q1Q2Q3Q4 (consolidated) 

3.Other Reports 


 
 


TWSEYearCategoryDescriptionNoteDownloads
16930971june 2011disclosure statementsupplementary public offering (manuscript)Bioptik .co supplemented the public offering201106_16930971_B032.pdf
4161july 2011disclosure statementINITIAL APPLICATION FOR LISTING, CABINET (XING CABINET) OR TDRBioptik .co cabinet with a public instruction manual201107_4161_B07.pdf
4161december 2012disclosure statementINITIAL APPLICATION FOR LISTING, TDR 201212_4161_B07.zip
4161january 2013disclosure statementINITIAL APPLICATION FOR LISTING, TDRupdated december 2011 uploaded pages 88 and 91 pages201301_4161_B07.zip
4161may 2013disclosure statementpital increase (draft)gold capital increase issuance of new shares for pre-counter public underwriting and initial use of shares on the counter (price tentative)201305_4161_B013.zip
4161june 2013disclosure statementpital increase (draft)cash capital increase issuance of new shares for pre-counter public underwriting and initial use of shares on the counter (price tentative)201306_4161_B011.pdf
4161june 2013disclosure statementcapital increase issuance
initial cash replenishment price determination version201306_4161_B04.pdf
4161december 2013disclosure statementarious types of corporate bonds (draft) 201312_4161_B021.pdf
4161january 2013disclosure statementcapital increase (draft) 201401_4161_B05.pdf
4161december 2014disclosure statementpital increase (draft) 201412_4161_B011.pdf
4161january 2015disclosure statementcapital increase issuance
price determination version201501_4161_B04.pdf
4161march 2015disclosure statementcapital increase issuance
take effect201503_4161_B04.pdf
Copyright  ©  2011  BIOPTIK LTD.  All rights reserved. Design  by  GRNET